Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
ConclusionsDAAs after HCC treatment prevents deterioration of hepatic functional reserve and significantly improves both recurrence and survival rates.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Bilirubin | Cancer & Oncology | Carcinoma | Children | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver Cancer | Study